Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306877 · ClinicalTrials.gov registry record · NA
Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT01306877: Completed NA study, sponsored by Medtronic - MITG.
NCT01306877 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 149 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01306877, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set for the treatment of hemorrhoids is non-inferior to the competitor device based on the primary endpoint.
Primary Outcome
Number of subjects who require intervention to stop intraoperative bleeding The analysis is based on the per protocol analysis set. Subjects who were misrandomized for excluded from this analysis therefore, the population here will differ from the participant flow.
Interventions
- DEVICE EEA Hemorrhoid and Prolapse Stapling Set
- DEVICE Endosurgery Proximate PPH03 Stapling Set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT01306877 record still lists
NCT01306877 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which EEA Hemorrhoid and Prolapse Stapling Set is the first listed.
NCT01306877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01306877 about?
NCT01306877 is a clinical study titled "Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids". The purpose of this study is to demonstrate that the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set for the treatment of hemorrhoids is non-inferior to the competitor device based on the primary endpoint.
What is the current status of trial NCT01306877?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2011-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01306877?
The interventions under investigation include: EEA Hemorrhoid and Prolapse Stapling Set (DEVICE), Endosurgery Proximate PPH03 Stapling Set (DEVICE).
Who is sponsoring clinical trial NCT01306877?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01306877's enrollment target sits among peer trials
149 702nd of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia